Redwood Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-214,862
Closed -$7.95M 125
2022
Q1
$7.95M Buy
214,862
+117
+0.1% +$4.56K 0.75% 58
2021
Q4
$9.77M Sell
214,745
-745
-0.3% -$38.9K 0.77% 52
2021
Q3
$13.7M Sell
215,490
-13,839
-6% -$1.05M 1.14% 37
2021
Q2
$21M Buy
229,329
+27,147
+13% +$2.16M 1.69% 20
2021
Q1
$13.8M Sell
202,182
-32,695
-14% -$2.54M 1.21% 38
2020
Q4
$17M Sell
234,877
-242,387
-51% -$14M 1.45% 29
2020
Q3
$18.1M Sell
477,264
-27,980
-6% -$945K 1.53% 23
2020
Q2
$17.9M Sell
505,244
-199,290
-28% -$5.67M 1.58% 23
2020
Q1
$15.4M Buy
704,534
+264,827
+60% +$5.93M 1.82% 13
2019
Q4
$9.48M Sell
439,707
-20,211
-4% -$464K 0.89% 52
2019
Q3
$10.4M Buy
459,918
+21,511
+5% +$596K 0.8% 54
2019
Q2
$15.8M Buy
438,407
+81,932
+23% +$2.62M 1.16% 31
2019
Q1
$11.2M Buy
+356,475
New +$10.4M 0.82% 65

Other funds holding CDNA

Redwood Investments's CDNA Position: Q2 2022 in Review

Redwood Investments sold out of CareDx (CDNA) in Q2 2022, closing a stake of 214,862 shares — an estimated $7.95M sold.

Redwood Investments first reported a position in CDNA in Q1 2019 and held it in 13 quarters. The position peaked at $21M in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Redwood Investments reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Redwood Investments sold 214,862 CareDx shares in Q2 2022, an estimated $7.95M.
  • Redwood Investments first reported a position in CareDx in Q1 2019 and held it in 13 quarters.
  • Redwood Investments's CareDx position peaked at $21M in Q2 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Redwood Investments's 13F filing for Q2 2022, filed 15 Jul 2022.